SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced the appointments of Karah Parschauer, J.D., to its Board of Directors and of Joanna Auch as Senior Vice […]
Author: Ken Dropiewski
Getinge acquires Talis Clinical LLC, a leading innovator of High Acuity cloud-based software solutions
GOTHENBURG, Sweden, Dec. 23, 2021 /PRNewswire/ — Getinge announces the acquisition of 100% of the equity interest in Talis Clinical LLC, a US-based leading innovator of High Acuity cloud-based software solutions. Talis Clinical’s offer is designed to support and document care throughout the general and cardiac perioperative care process, but also through labor […]
FDA Grants Marketing Authorization for Inferior Vena Cava Filter Removal Device
SILVER SPRING, Md., Dec. 21, 2021 /PRNewswire/ — Today, the U.S. Food and Drug Administration authorized marketing of the first laser-based device for the removal of Inferior Vena Cava (IVC) filters. The device is designed for patients who have an IVC filter, a small cage-like device inserted into the largest vein in […]
Biovo Technologies signs a prospective, observational, crossover pilot study for Cuffix™ with a leading US Hospital
Comparison of 24-hour endotracheal tube cuff pressure continuously adjusted with a novel device – Cuffix™ to manually adjusted cuff pressures ROSH HA’AYIN, Israel, Dec. 20, 2021 /PRNewswire/ — Biovo Technologies Ltd. (“Biovo”), a medical device company focused on devices for Critical Care and Operating Rooms, announced today it has signed an agreement with […]
FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
XARELTO® is available as both an oral tablet and oral suspension formulation for use in appropriate children less than 18 years of age Convenient oral suspension formulation advances standard of care for children; alleviates administration challenges found with injectable alternatives XARELTO® now has 11 indications, the most of any direct […]
CytoSorbents Appoints Daniel Wendt, MD, PhD, MHBA, FECTS as Vice President, Medical Affairs Cardiovascular
MONMOUTH JUNCTION, N.J., Dec. 21, 2021 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces the appointment of Professor Daniel Wendt, MD, PhD, MHBA, FETCS as Vice President, Medical Affairs Cardiovascular commencing January 1, 2022. Dr. Wendt is an internationally renowned […]
First Clinical Study on TRIA Biopolymer Heart Valve Shows Excellent One-Year Performance
Publication in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions Found TRIA Aortic Heart Valve Provided Sustained Improvement in Heart Valve Function to One-Year with Good Safety Profile SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced publication of the first clinical results for its TRIA™ biopolymer heart valve – […]
St. Joseph’s Children’s Hospital First in Florida to Use Breakthrough Device for Non-Surgical Pulmonary Valve Replacement
The revolutionary Harmony Transcatheter Pulmonary Valve is placed via cardiac catheterization and provides an alternative to open-heart surgery for patients with leaky pulmonary valves. TAMPA, Fla., Dec. 20, 2021 /PRNewswire/ — Jasmine Harvey, 21, was born with the complex congenital heart condition tetralogy of Fallot and underwent open-heart surgery at St. Joseph’s Children’s Hospital when she […]
Cardiovascular Startup, Filterlex Medical, Selected to Receive €7M from the European Innovation Council
Equity investment to support advancement of its breakthrough full-body embolic protection device to reduce the risk of stroke and other complications during left-heart procedures. CAESAREA, Israel, Dec. 21, 2021 /PRNewswire/ — Filterlex Medical, a cardiovascular medical device startup, announced today that it has been selected to receive €7 Million equity investment from the European […]
CHILDREN’S HOSPITAL COLORADO FIRST PEDIATRIC HOSPITAL TO TREAT PATIENTS USING 3D INTRACARDIAC ECHOCARDIOGRAPHY CATHETER
3D ICE improves standard of care for congenital heart disease and electrophysiology procedures by reducing need for general anesthesia, improving efficiency and expanding treatment options AURORA, Colo., Dec. 20, 2021 /PRNewswire/ — Children’s Hospital Colorado (Children’s Colorado) is the first pediatric hospital in the world to use a 3D intracardiac echocardiography (ICE) catheter […]



